Characteristics of Intestinal Microbiome Following Pancreatic Surgery
1 other identifier
observational
20
1 country
1
Brief Summary
The goal of this observational study is to learn about intestinal microbiome structure and function in individuals who have undergone a pancreatoduodenectomy and compare to healthy matched controls. The primary objectives of the study are:
- Three-day food, bowel and medication diary (see Protocol appendix 5)
- Gastrointestinal Symptom Rating Scale (see Protocol appendix 6)
- Quality of life questionnaire (see Protocol appendix 7)
- Stool sample test using Microba Insight TradeMark (a small swab is taken from soiled toilet paper, sealed in a room-temperature storage capsule and mailed to the testing laboratory)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJuly 24, 2025
July 1, 2024
1 year
March 6, 2024
July 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of microbiota profile between post-surgical participants and healthy controls.
Stool samples will be analysed to compare the Shannon diversity index (calculated by taking the number of each microbial species, the proportion each species is of the total number of individuals, summed by the proportion times the natural log of the proportion for each species) between participant groups.
During data collection, 3 days
Secondary Outcomes (6)
Compliance with 3-day food dairies
From enrollment to the collection of data from participants, 3 days
Pre-paid return rates
From enrollment to the collection of data from participants, 3 days
Ease of matching
Enrollment period, up to 12 months
Shannon diversity index
During data collection period, 3 days
Gastrointestinal symptoms
During data collection period, 3 days
- +1 more secondary outcomes
Study Arms (2)
Post-surgical patients
Adults having had pancreatoduodenectomy (Whipple's) surgery for curative intent.
Matched controls
Participants matched to each post-surgical participant by age, sex, body mass index (BMI), smoking status.
Eligibility Criteria
Post-surgical patients are adults (aged ≥ 18 years) who have undergone a pancreatoduodenectomy (Whipple's) surgery for curative between the time period of April 2018 - December 2023, and received post-operative clinical management at Royal Prince Alfred Hospital. Healthy adults (matched controls) will be matched by age, sex, body mass index and smoking status.
You may qualify if:
- Adults (aged equal to or greater than 18 years) having had pancreatoduodenectomy (Whipple's) surgery between April 2018 - December 2023 for curative intent and received post-operative clinical management at Royal Prince Alfred Hospital, (post-surgical participants), and
- Healthy adults matched by age, sex, body mass index and smoking status
You may not qualify if:
- Aged less than 18 years
- Are unable to complete the questionnaires or testing due to language or cognitive limitations
- Have active or recurring pancreatic cancer, or where the surgery was for non-curative intent
- Have other gastrointestinal conditions that could affect gut symptoms or microbiome such as Inflammatory Bowel disease, Irritable Bowel Syndrome Coeliac disease, or are currently pregnant or breastfeeding
- Are currently taking medications or diet that can affect gut symptoms or microbiome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nutrition and Dietetics, Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
Biospecimen
Stool samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Dietitian
Study Record Dates
First Submitted
March 6, 2024
First Posted
March 20, 2024
Study Start
August 1, 2024
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
July 24, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share